Scleroderma Foundation Statement on COVID-19 Vaccine

Dear Friends,

I hope that you are doing well in these challenging times.

Many people have asked us about recommendations for people with scleroderma related to COVID-19 vaccines. You may remember that when the pandemic began the Scleroderma Foundation in the United States pulled together a talented group of experts and provided a great page with information and recommendations for patients. That same group has now provided a page with information and recommendations on COVID-19 vaccines that will be, I think, of great interest to people with scleroderma. People have lots of questions, and there is both good and bad information being provided to them. This page has highly credible information from some of the top experts in the world: https://www.scleroderma.org/site/SPageServer?pagename=patients_COVID19_MSAB_Vaccines&AddInterest=1281#.X_uHvOByays

Thanks to the Scleroderma Foundation for providing this to our community!

Cheers, Brett

Brett D. Thombs, Ph.D. Professor, Faculty of Medicine, McGill University Senior Investigator, Lady Davis Institute of Medical Research, Jewish General Hospital Canada Research Chair (Tier 1) Member, College of the Royal Society of Canada Fellow, Canadian Academy of Health Sciences https://www.thombsresearchteam.ca/ Chair, Canadian Task Force on Preventive Health Care (CTFPHC) Director, Scleroderma Patient-centered Intervention Network (SPIN) Director, DEPRESsion Screening Data (DEPRESSD) Project